Leading global clinical trial supply companies UK/US/Europe: Global clinical trial supply services tailored for you! Strategic Sourcing – ClientPharma’s ethos is to challenge the norms and adapt to your specific needs. We understand the difficulties of multi-faceted projects with time and temperature delivery requirements. Biosimilars & Reference Medicines – ClientPharma’s clinical trial Project Management team brings proficiency in management and mitigation of risks. You can say goodbye to issues and delays and hello to peace-of-mind. See additional details at biosimilars and reference medicines.
We are dedicated to delivering on point and on time, every time, no matter how technically challenging. As one of the top global clinical trial supply companies, our worldwide reach for clinical trial supply services provides unrivalled capabilities. Our clinical supply partners are leading global innovators and manufacturers as well as specialty distributors and local in-country experts. Benefit from the expertise of our highly experienced team who will give swift and practical advice on how best to effectively supply the products you need and exactly when and where you need them!
From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.
Our temperature-controlled capabilities include 2°- 8°C and 15°- 25°C facilities, as well as access to specialist transport to manage deliveries around the world according to product temperature requirements. Extensive capabilities: Our capabilities include stock receipt, import & export expertise, in-territory regulatory specialists, product reconciliation and destruction services. You can trust us: Our highly trained logistics team is dedicated to providing a robust clinical trial supply chain and trusted product integrity with regulatory compliant distribution through validated temperature-controlled logistics. We provide the peace-of-mind you need, offering you with dedicated clinical trial supply chain solutions to meet the explicit needs of your clinical programs. Discover more info on https://www.clientpharma.com/.
Under this partnership, clients will now enjoy an expanded reach by leveraging ClientPharma’s global sourcing, procurement and distribution logistics while also having the ability to utilize the RxStudy CardTM, TrialCard’s virtual inventory supply solution that has been augmented to place physical inventories of medication at sites for protocol designs that require immediate dosing. This will cut supply costs by 50% and reduce clinical supply teams’ efforts by 80%. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”
Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.